The trial would evaluate the safety and efficacy of a new stem cell-derived encapsulated cell replacement therapy, known officially as VC-O1. Basically, that product uses pancreas endoderm cells derived from embryonic stem cells and would be put into the body using something called the Encaptra delivery system.
NewsFlash: Insulin Release Band-Aid Sized Encapsulation Device Goes to FDA!
Posted in Artificial Pancreas